Roche acquires GNMK for $24.05 cash—a 30% premium to Friday’s close, and a 43% premium to GNMK’s “unaffected” share price on 2/10/21 (before leaks of the buyout discussions):
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.